Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2009 1
2011 2
2012 1
2013 1
2014 1
2016 3
2017 6
2018 14
2019 2
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

37 results
Results by year
Filters applied: . Clear all
Page 1
Eteplirsen in the treatment of Duchenne muscular dystrophy.
Lim KR, Maruyama R, Yokota T. Lim KR, et al. Among authors: maruyama r. Drug Des Devel Ther. 2017 Feb 28;11:533-545. doi: 10.2147/DDDT.S97635. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28280301 Free PMC article. Review.
Nusinersen in the Treatment of Spinal Muscular Atrophy.
Goodkey K, Aslesh T, Maruyama R, Yokota T. Goodkey K, et al. Among authors: maruyama r. Methods Mol Biol. 2018;1828:69-76. doi: 10.1007/978-1-4939-8651-4_4. Methods Mol Biol. 2018. PMID: 30171535 Review.
Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
Echigoya Y, Lim KRQ, Trieu N, Bao B, Miskew Nichols B, Vila MC, Novak JS, Hara Y, Lee J, Touznik A, Mamchaoui K, Aoki Y, Takeda S, Nagaraju K, Mouly V, Maruyama R, Duddy W, Yokota T. Echigoya Y, et al. Among authors: maruyama r. Mol Ther. 2017 Nov 1;25(11):2561-2572. doi: 10.1016/j.ymthe.2017.07.014. Epub 2017 Jul 28. Mol Ther. 2017. PMID: 28865998 Free PMC article.
Exons 45-55 Skipping Using Mutation-Tailored Cocktails of Antisense Morpholinos in the DMD Gene.
Echigoya Y, Lim KRQ, Melo D, Bao B, Trieu N, Mizobe Y, Maruyama R, Mamchaoui K, Tanihata J, Aoki Y, Takeda S, Mouly V, Duddy W, Yokota T. Echigoya Y, et al. Among authors: maruyama r. Mol Ther. 2019 Nov 6;27(11):2005-2017. doi: 10.1016/j.ymthe.2019.07.012. Epub 2019 Jul 26. Mol Ther. 2019. PMID: 31416775
Skipping Multiple Exons to Treat DMD-Promises and Challenges.
Aslesh T, Maruyama R, Yokota T. Aslesh T, et al. Among authors: maruyama r. Biomedicines. 2018 Jan 2;6(1):1. doi: 10.3390/biomedicines6010001. Biomedicines. 2018. PMID: 29301272 Free PMC article. Review.
Designing Effective Antisense Oligonucleotides for Exon Skipping.
Shimo T, Maruyama R, Yokota T. Shimo T, et al. Among authors: maruyama r. Methods Mol Biol. 2018;1687:143-155. doi: 10.1007/978-1-4939-7374-3_10. Methods Mol Biol. 2018. PMID: 29067661
Systemic and ICV Injections of Antisense Oligos into SMA Mice and Evaluation.
Aslesh T, Maruyama R, Yokota T. Aslesh T, et al. Among authors: maruyama r. Methods Mol Biol. 2018;1828:455-465. doi: 10.1007/978-1-4939-8651-4_28. Methods Mol Biol. 2018. PMID: 30171559
Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates.
Lim KRQ, Echigoya Y, Nagata T, Kuraoka M, Kobayashi M, Aoki Y, Partridge T, Maruyama R, Takeda S, Yokota T. Lim KRQ, et al. Among authors: maruyama r. Mol Ther. 2019 Jan 2;27(1):76-86. doi: 10.1016/j.ymthe.2018.10.011. Epub 2018 Oct 19. Mol Ther. 2019. PMID: 30448197 Free PMC article.
Tips to Design Effective Splice-Switching Antisense Oligonucleotides for Exon Skipping and Exon Inclusion.
Maruyama R, Yokota T. Maruyama R, et al. Methods Mol Biol. 2018;1828:79-90. doi: 10.1007/978-1-4939-8651-4_5. Methods Mol Biol. 2018. PMID: 30171536
In Vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs.
Maruyama R, Aoki Y, Takeda S, Yokota T. Maruyama R, et al. Methods Mol Biol. 2018;1828:365-379. doi: 10.1007/978-1-4939-8651-4_23. Methods Mol Biol. 2018. PMID: 30171554
37 results
Jump to page
Feedback